EGM
DAWN

Engineers Gate Manager’s Day One Biopharmaceuticals DAWN Stock Holding History

Engineers Gate Manager’s Portfolio DAWN Stock Details DAWN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$624K Buy
+29,093
New +$410K 0.01% 1281
2025
Q2 		– Sell
-17,291
Closed -$137K – 2225
2025
Q1 		$137K Buy
+17,291
New +$186K ﹤0.01% 1964

Other funds holding DAWN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
KC
Kryger Capital London, United Kingdom $1.41B AUM 86.31% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return

Engineers Gate Manager's DAWN Position: Q1 2026 in Review

Engineers Gate Manager opened a new position in Day One Biopharmaceuticals (DAWN) in Q1 2026: 29,093 shares worth $624K. The stake represents 0.01% of the portfolio and ranks #1281 among its holdings. This is a return to the name: Engineers Gate Manager previously reported a position in DAWN as recently as Q1 2025.

Engineers Gate Manager first reported a position in DAWN in Q1 2025 and has held it in 2 quarters since. 206 funds tracked by Wall St. Rank hold DAWN as of Q1 2026.

  • Engineers Gate Manager held 29,093 shares of Day One Biopharmaceuticals worth $624K as of Q1 2026.
  • Day One Biopharmaceuticals was a new Engineers Gate Manager position in Q1 2026.
  • Day One Biopharmaceuticals made up 0.01% of Engineers Gate Manager's portfolio in Q1 2026, its #1281 holding.
  • Engineers Gate Manager first reported a position in Day One Biopharmaceuticals in Q1 2025 and has held it in 2 quarters since.
  • 206 funds tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q1 2026.

Based on Engineers Gate Manager's 13F filing for Q1 2026, filed 15 May 2026.